Navigation Links
NeuroDerm Announces Positive Results of a Phase I Study of ND0612 for the Treatment of Parkinson's Disease
Date:3/4/2013

NESS ZIONA, Israel, March 4, 2013 /PRNewswire/ --

NeuroDerm, Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously sub-cutaneously through a patch pump. It is designed to provide steady levodopa blood levels for the reduction of motor complications in Parkinson's disease. Results of this study support the continued development of ND0612 for the treatment of Parkinson's disease.

In this double-blind, placebo controlled, dose-escalation trial in young, healthy volunteers, ND0612 was shown to be safe and tolerable in all of the tested doses. Furthermore, clinically meaningful levodopa concentrations were reached and, for the first time in man, steady state levodopa concentrations were maintained in a practical manner both day and night. The full results of this study will be presented at a future scientific meeting.

"ND0612's success in its first phase I trial means that clinically significant steady state levodopa concentrations can, for the first time, be maintained, both day and night, through a conveniently administered drug. With ND0612, steady state levodopa levels, the elusive holy grail of Parkinson's levodopa therapy, should be available to all PD patients. Moreover, as ND0612 bypasses the gastrointestinal tract, steady state levodopa levels should be little influenced by intestinal absorption or oral ingestion of food or drugs. We believe that ND0612 could become a breakthrough treatment option that may establish a new, significantly higher standard of care for Parkinson's patients."

About Parkinson's Disease

Parkinson's disease affects approximately 6 million patients in the world. It is caused by decreasing dopamine signaling in the brain as dopam
'/>"/>

SOURCE NeuroDerm Ltd
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NeuroDerm Announces Enrollment in a Phase 1 Study of ND0612, a Continuous Levodopa/Carbidopa Drug for the Treatment of Parkinsons Disease
2. Ryan & Maniskas, LLP Announces Class Action Lawsuit Against Affymax, Inc.
3. PDL BioPharma Announces Fourth Quarter and Full Year 2012 Financial Results
4. Hospira Announces Executive Changes
5. Citiustech Announces Launch of Bi-Clinical Cloud and App-Based Architecture
6. DMH International Announces FDA Approval of TouchPACS
7. ADVENTRX Announces Corporate Name Change To "Mast Therapeutics, Inc."; Ticker Symbol Change To "MSTX"
8. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
9. Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference
10. Rigel Announces Participation at Two Investor Conferences
11. Pharmacy Technician Certification Board Announces Certification Program Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... Research and Markets ( http://www.researchandmarkets.com/research/pmbmv2/global_biobanking ) ... Market 2015-2019" report to their offering. ... at a CAGR of 7.07% over the period 2014-2019 ... into two segments: Equipment and Consumables. This report covers ... Global Biobanking market for the period 2015-2019. ...
(Date:4/24/2015)... , April 24, 2015  Novartis Pharmaceuticals Corporation (NPC) has ... year in a row on the annual DiversityInc Top 50 ... 2015 Top 50 Companies for Diversity on April 23 at ... . NPC also ranked second on the DiversityInc Top 10 ... Companies for Employee Resource Groups list. ...
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
Breaking Medicine Technology:Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 2Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 3Novartis Pharmaceuticals Corporation is first company to receive number one ranking two years in a row on DiversityInc Top 50 Companies for Diversity list 4Lannett Expands Revolving Credit Facility To $120 Million 2
(Date:4/26/2015)... 26, 2015 The grand celebration got off ... Deb Dettor, CCAR’s Managing Director. Deb then introduced Sandy Valentine, ... not in attendance because of his Walk for Recovery ... was able to express his gratitude to the volunteers via ... their dedication to carrying out CCAR’s mission. Volunteer Manager ...
(Date:4/25/2015)... April 25, 2015 In observance of ... join The Million Nets Pledge, a two-year pledge by ... protect refugee families with one million bednets by 2016. ... work with UN partners to protect children, refugees, and ... , “There has been a large surge in ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 By definition, a ... data for the enterprise relying on their judgement and expertise ... But according to an article published in National ... times actually be doing a disservice to their responsibilities by ... dotted and t’s are crossed when it comes to company ...
(Date:4/25/2015)... York New York (PRWEB) April 25, 2015 ... that Dr. Jerry Blaivas has been chosen by the New ... for his contributions to medicine in the field of Urology. ... the best in his speciality, Genito-Urinary diseases. He was ... specifically in the field of urology. Not only did ...
(Date:4/24/2015)... NY (PRWEB) April 24, 2015 Constellations ... living residence in Westchester County. Just 35 miles from ... transition individuals back into everyday life while recovering from ... May 7, 2015, will allow therapists, doctors and treatment ... and learn more about the opportunities offered by Constellations ...
Breaking Medicine News(10 mins):Health News:The Connecticut Community for Addiction Recovery (CCAR) honors its volunteers during National Volunteer Recognition Week. 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 2Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 3Health News:Supporters Worldwide Join The Million Nets Pledge on World Malaria Day 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 2Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 3Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 4Health News:An Outsider’s Perspective on Cyber Security Can Only Benefit CIOs 5Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 2Health News:Constellations Recovery Opens The First Luxury Sober Living Residence in Westchester New York 3
... arrest who received intensive care can expect long-term quality ... system. Research published today in BioMed Central,s open access ... show that the allocation of resources to the treatment ... the treatment of other intensive care patient groups. , ...
... ... Research, Project Made Possible ... to Advancing Breakthrough Spinal Cord Discoveries, WASHINGTON, July 17 The ... the,world,s first genome-wide map of the mouse spinal cord. Researchers can,immediately access ...
... Certification Commission for Healthcare Information Technology (CCHIT®) today ... Certified®, and meets the Commission's ambulatory electronic health ... products with the CCHIT Certified seal, physicians and ... an EHR product, allowing them to focus their ...
... First Mobile Medical Service for Access to Qualified Health ... ... HTH Worldwide, a global health and,safety services company, today introduced ... access to HTH Worldwide,s databases of global health and safety,information when ...
... Pa., July 17 Universal,Health Services, Inc. (NYSE: ... to pay a cash dividend of $0.08 per share ... September 2, 2008., Universal Health Services, Inc. is ... subsidiaries, acute care and behavioral,health hospitals, and ambulatory centers ...
... disaster season continues with the response to California,wildfires, ... Fire Protection today reported 80 active,wildfires still burning in ... 17 shelters since early June to help those who ... relief operation has served more than 21,000 meals and,snacks, ...
Cached Medicine News:Health News:Heart attack not a death sentence 2Health News:Video: Allen Institute for Brain Science Unveils World's First Genome-Wide Spinal Cord Atlas 2Health News:Video: Allen Institute for Brain Science Unveils World's First Genome-Wide Spinal Cord Atlas 3Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 2Health News:gloEMR Version 4.0, gloStream's Flagship Electronic Medical Record Solution, Receives 2007 CCHIT Certification 3Health News:HTH Worldwide Introduces mPassport(sm), Mobile Health and Safety 2Health News:HTH Worldwide Introduces mPassport(sm), Mobile Health and Safety 3Health News:As Fires Burn, Red Cross Brings Relief to Weary California 2Health News:As Fires Burn, Red Cross Brings Relief to Weary California 3
Cannulated Interference Screws...
Cannulated Interference Screws...
... CoEase is designed to provide excellent ... the unique advantage of being closer to ... cohesives. This allows CoEase to maintain ... the best of both worlds for superb ...
Finally, a camera that sees the way you do!,Combined with the MicroLux DVR (Digital Video Recorder), the MicroLux Headlight Camera System gives you an entirely new way to visualize, edit, share and...
Medicine Products: